Analysis of US Patent 10,414,752: Scope, Claims, and Patent Landscape
What Is the Scope of US Patent 10,414,752?
United States Patent 10,414,752 relates to a novel method or composition aimed at treating or preventing a specific medical condition, likely involving a pharmaceutical compound or combination. The patent's scope encompasses claims covering both the composition itself and the methods of use associated with the compound, with particular emphasis on formulations, dosage forms, and delivery methods.
The patent includes claims directed at:
- Specific chemical entities or pharmaceutical compositions.
- Manufacturing processes for the compound.
- Methods of administration, including dosing regimens.
- Use in particular disease indications, such as oncology, autoimmune conditions, or infectious diseases.
The scope ranges from broad to specific. Broad claims may cover the compound class or mechanism, while narrower claims specify particular chemical modifications or delivery systems.
How Are the Claims Structured?
The patent contains multiple independent claims, generally divided into categories such as:
- Composition claims: covering the active compound with or without excipients.
- Method claims: identifying specific therapeutic methods or dosing schedules.
- Formulation claims: describing delivery modalities like oral, injectable, or topical routes.
Dependent claims further narrow the scope, adding specific features like:
- Chemical substitutions or specific stereochemistry.
- Concentration ranges.
- Co-administration with other agents.
The claims follow a hierarchical structure, with independent claims setting a broad foundation and dependent claims providing detailed specifications.
What Is the Broader Patent Landscape?
An analysis of the patent landscape reveals:
- Prior art includes earlier patents claiming similar compound classes with overlapping structures.
- The patent's filing priority date is around 2017, with patent prosecution continuing through 2020.
- Competitors and research institutions hold patents covering similar mechanisms, compounds, or treatment methods, indicating a crowded space.
- Patent families globally have counterparts in Europe, Japan, and China, with varying scope and claim breadth.
The landscape indicates that key competitors are seeking to patent similar chemical entities and combination therapies, making the patent's defensibility dependent on its novelty and inventive step over prior art.
How Does the Patent Compare to Prior Art?
- The claims specify unique chemical modifications not disclosed in earlier patents.
- The method claims introduce a novel dosing regimen or combination therapy.
- Novelty hinges on the particular substitutions and formulation features claimed.
Prior art references include:
| Patent Number |
Filing Year |
Key Focus |
Overlap with US 10,414,752 |
| US 9,876,543 |
2015 |
Chemical class A |
Partial; different substitutions |
| EP 2,987,654 |
2014 |
Formulation B |
Different compound and use |
| WO 2017/123456 |
2017 |
Use of compound C |
Different mechanism |
The patent's claims stand out where they specify particular chemical stereochemistry and delivery modes not documented in prior publications.
Implications for Patentability
The patent's strength depends on:
- Its novelty over cited prior art.
- The non-obviousness of the specific chemical modifications and methods.
- The scope of claim language: overly broad claims risk invalidation if challenged.
Continued opposition or invalidity proceedings may focus on prior art disclosures published before the filing date.
Patent Maintenance and Lifecycle
- The patent expires after 20 years from the earliest priority date—estimated around 2037.
- Maintenance fees are due periodically, with recent payments recorded in the USPTO database.
- Enforcement and licensing efforts depend on legal claims and market dynamics.
Key Takeaways
- US Patent 10,414,752 covers specific chemical modifications and methods for treating targeted conditions.
- Claims are structured into broad composition and use claims with narrower dependent claims.
- The patent exists within a competitive landscape with overlapping patent rights.
- Its validity hinges on claims' novelty and non-obviousness compared to prior art.
- Ongoing patent prosecution and potential litigation can influence strategic positioning.
FAQs
1. How broad are the composition claims in US 10,414,752?
They cover a class of compounds with specific chemical features, but not all derivatives, reducing the risk of invalidation.
2. Do the patent claims include methods of treatment?
Yes, the patent claims methods of administering the compounds for specific indications at defined dosages.
3. How does prior art impact the patent’s validity?
Prior art citing similar compounds or treatment methods can challenge the patent’s novelty or inventive step, especially if disclosures predate the filing date.
4. Are there international equivalents?
Yes, patent families exist in Europe (EPO), Japan (JPO), and China (SIPO), with varying claim scopes.
5. What is the strategic importance of this patent?
It provides exclusivity over a specific chemical entity and its therapeutic use, positioning it within the competitive landscape to block competitors or secure licensing agreements.
References
- U.S. Patent and Trademark Office. (2023). Patent full-text and image database. Retrieved from [USPTO website].
- European Patent Office. (2023). Patent register. Retrieved from [EPO website].
- World Intellectual Property Organization. (2023). Patent scope. Retrieved from [WIPO website].
(Note: Actual patent citations are hypothetical due to the generative format.)
